Epinephrine 1.82 mg/ml solution for injection, Ampicillin... Azithromycin 500 mg tablets/capsules, Albumin 20% infusion solution, Amikacin, Chlorpromazine, Amoxicillin and clavulanic acid, Ibuprofen infusion solution, Povidone-iodine, Gentamicin

01

The municipal non-profit enterprise 'Sniatyn Multi-Profile Hospital' of the Sniatyn City Council awarded a public contract for the supply of medicines. The list includes epinephrine 1.82 mg/ml injection solution, azithromycin 500 mg tablets and capsules, albumin 20% and 20%-25% infusion solutions in 50 ml and 100 ml, amikacin 250 mg/ml injection solution, chlorpromazine 25 mg/ml, amoxicillin with clavulanic acid 1.2 g powder, ibuprofen 4 mg/ml infusion solution, povidone-iodine 10% and gentamicin injection solution. The contract was awarded to LLC 'GALYCH-POLYMED' for UAH 470,000. The estimated value was UAH 470,000. The award date was 2026-08-20, with bids due by 2026-08-19. Bidders confirmed the goods are not of Russian, Belarusian or Iranian origin.

02

Description

03

Recent awards

• Sodium metamizole injection solution 500 mg/ml, 2 ml; Hydroxyethyl starch 6%, 200 ml; Paracetamol infusion solution 10 mg/ml, 100 ml; Enoxaparin sodium injection solutions; Omeprazole 40 mg vials; Cefazolin powder for injections 1 g; Ondansetron injection solution

  awarded to Товариство з обмеженою відповідальністю "Юрія-фарм"

• 10-panel urine drug test: amphetamine (AMP500)/cocaine (COC300)/marijuana (THC50)/methamphetamine (MET500)/morphine (MOP300)/phencyclidine (PCP25)/benzodiazepines (BZO300)/ecstasy (MDMA500)/methadone (MTD300)/barbiturates (BAR300)

  awarded to Товариство з обмеженою відповідальністю "ЕКСДІА ПЛЮС"

• 10-drug combined urine test: amphetamine (AMP500)/cocaine (COC300)/marijuana (THC50)/methamphetamine (MET500)/morphine (MOP300)/phencyclidine (PCP25)/benzodiazepines (BZO300)/ecstasy (MDMA500)/methadone (MTD300)/barbiturates (BAR300)

  awarded to Товариство з обмеженою відповідальністю "ЕКСДІА ПЛЮС"

05

Market context

Avg. open tender · Medical equipment & pharmaceuticals

€11,306,115

10,020 open across Europe right now

Buyer track record on Aperlena

50 notices tracked · 43 awarded